Impact of Fluvoxamine on outpatient treatment of COVID-19 in Honduras

Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, Jose Garay Umanzor, Fernando Baires, Luis G. Benitez, Cesar Burgos, Anupamjeet Kaur Sekhon, Nicole Crisp, Anita S. Lewis, Jana Radwanski, Marco Bermudez, Karen Sanchez Barjun, Oscar Diaz, Elsa Palou, Rossany E. Escalante, Carlos Isai Hernandez, Mark L. Stevens, Deke Eberhard, Manuel Sierra, Tito Alvarado, Omar Videa, Miguel Sierra-Hoffman, Fernando Valerio Pascua
doi: https://doi.org/10.1101/2022.09.27.22280428

Article usage

Article usage: October 2022 to December 2024

AbstractFullPdf
Oct 202217167207
Nov 2022154231
Dec 2022105934
Jan 202366714
Feb 202354416
Mar 20235859
Apr 202343517
May 20232247
Jun 20231253
Jul 20232126
Aug 2023231110
Sep 202346911
Oct 20232788
Nov 20232092
Dec 20231725
Jan 20241524
Feb 2024411012
Mar 20242317
Apr 2024281111
May 20242327
Jun 20242124
Jul 20242527
Aug 2024401014
Sep 20243529
Oct 202435119
Nov 202443319
Dec 20241613
Back to top
Posted October 04, 2022.
Download PDF
Data/Code
Email
Impact of Fluvoxamine on outpatient treatment of COVID-19 in Honduras
Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, Jose Garay Umanzor, Fernando Baires, Luis G. Benitez, Cesar Burgos, Anupamjeet Kaur Sekhon, Nicole Crisp, Anita S. Lewis, Jana Radwanski, Marco Bermudez, Karen Sanchez Barjun, Oscar Diaz, Elsa Palou, Rossany E. Escalante, Carlos Isai Hernandez, Mark L. Stevens, Deke Eberhard, Manuel Sierra, Tito Alvarado, Omar Videa, Miguel Sierra-Hoffman, Fernando Valerio Pascua
medRxiv 2022.09.27.22280428; doi: https://doi.org/10.1101/2022.09.27.22280428
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area